In the presence of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP; used to induce PD symptoms in animal models), AQP4-KO astrocytes failed to upregulate TGF-β1 expression (Xue et al., 2019). Here, AQP4 is linked to Parkinson disease.